Vadaskert Alapitvany A Gyermekek Lelki Egeszsegeert
- Address
- lock Available on a paid plan
Vadaskert Alapitvany A Gyermekek Lelki Egeszsegeert - Tourette's Disorder Research Center
Vadaskert Alapitvany A Gyermekek Lelki Egeszsegeert is a specialized research institution dedicated to advancing the understanding and treatment of neuropsychiatric conditions in children and adolescents. The center has established itself as a key contributor to clinical research focused on Tourette's Disorder and Tourette Syndrome, participating in pivotal multi-center trials that evaluate novel therapeutic interventions across diverse age groups.
- Long-term safety and efficacy studies of ecopipam tablets for Tourette's Disorder in pediatric, adolescent, and adult populations
- Phase IIb placebo-controlled trials assessing gemlapodect for tic severity reduction in Tourette Syndrome
- Multi-phase continuation studies evaluating sustained treatment outcomes and tolerability profiles
The center's research portfolio emphasizes comprehensive evaluation of treatment safety across the developmental spectrum, from children aged 6 years through adulthood. Through participation in international collaborative trials, the institution contributes valuable data on tic severity assessment using standardized instruments such as the YGTSS-R, supporting the development of evidence-based therapeutic options for patients living with Tourette's disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Janssen Cilag International1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vadaskert Alapitvany A Gyermekek Lelki Egeszsegeert
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Gemlapodect in Adult and Adolescent Tourette Syndrome: A Double-Blind, Placebo-Controlled, Phase IIb Study | Noema Pharma AG | Phase II | Not Recruiting | Jul 2024 | Jan 2026 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ecopipam Hydrochloride | 1 | Unknown | 2023-07-20 | 2023-07-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.